Details

Industries

Biotechnology,Pharmaceutical

Founded date

Jan 7, 2021

Number Of Employee

1 - 10

Operating Status

Active

Investor Type

Venture Capital

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.